Abstract
Randomized trials that studied clinical outcomes after percutaneous coronary intervention (PCI) with bare metal stenting versus coronary artery bypass grafting (CABG) are underpowered to properly assess safety end points like death, stroke, and myocardial infarction. Pooling data from randomized controlled trials increases the statistical power and allows better assessment of the treatment effect in high-risk subgroups.
Original language | English |
---|---|
Pages (from-to) | 1146-54 |
Number of pages | 9 |
Journal | Circulation |
Volume | 118 |
Issue number | 11 |
DOIs | |
Publication status | Published - 9 Sep 2008 |
Keywords
- Angioplasty, Balloon, Coronary
- Coronary Artery Bypass
- Coronary Artery Disease
- Humans
- Randomized Controlled Trials as Topic
- Stents
- Treatment Outcome